Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Carpal Tunnel Syndrome

Back to Topics
Contents
0%

Carpal Tunnel Syndrome

Comprehensive Gold Standard guide to carpal tunnel syndrome: anatomy, pathophysiology, clinical diagnosis, provocative tests, electrodiagnostic criteria, surgical release techniques for FRACS exam

complete
Updated: 2025-12-25
High Yield Overview

CARPAL TUNNEL SYNDROME

Median Nerve Entrapment | Most Common Compression Neuropathy | 9 Tendons + 1 Nerve

3-6%Population prevalence
3:1Female to male ratio
10Structures in tunnel (9T+1N)
95%Surgical success rate

CLINICAL SEVERITY

Mild
PatternIntermittent symptoms, normal exam
TreatmentSplinting 6-8 weeks
Moderate
PatternConstant symptoms, sensory deficit
TreatmentInjection or surgery
Severe
PatternThenar atrophy, motor weakness
TreatmentUrgent surgical release

Critical Must-Knows

  • Carpal tunnel contents: 9 flexor tendons (4 FDS + 4 FDP + FPL) + median nerve (most superficial)
  • Thenar atrophy = SEVERE: APB wasting indicates axonal loss, requires urgent surgery, incomplete recovery
  • Palmar cutaneous branch spared: Branches proximal to tunnel, preserves palmar sensation
  • Phalen's test: Wrist flexion 60 seconds reproduces symptoms (68% sensitive, 73% specific)
  • NCS criteria: Motor latency greater than 4.5ms, sensory latency greater than 3.5ms across wrist

Examiner's Pearls

  • "
    Nocturnal paresthesia with flick sign = virtually diagnostic
  • "
    Durkan's compression test (87% sensitive) better than Phalen's or Tinel's
  • "
    Open vs endoscopic CTR = similar outcomes, faster recovery with endoscopic
  • "
    Pillar pain (10-20%) = most common post-op complication, resolves by 3 months

Clinical Imaging

Imaging Gallery

Ultrasonography image of a median nerve in a patient with carpal tunnel syndrome.(A) Position of the ultrasound device with the wrist in a neutral position, palm facing up, and the fingers semi-extend
Click to expand
Ultrasonography image of a median nerve in a patient with carpal tunnel syndrome.(A) Position of the ultrasound device with the wrist in a neutral posCredit: Zhang L et al. via Neural Regen Res via Open-i (NIH) (Open Access (CC BY))
57-year-old female with recurrent right wrist carpal tunnel syndrome symptoms underwent revision surgery. Sonographic appearance of the transverse carpal tunnel after revision carpal tunnel release, a
Click to expand
57-year-old female with recurrent right wrist carpal tunnel syndrome symptoms underwent revision surgery. Sonographic appearance of the transverse carCredit: Shapiro SA et al. via J Clin Imaging Sci via Open-i (NIH) (Open Access (CC BY))
A 74-year-old male with recurrent carpal tunnel syndrome who underwent revision surgery of the left wrist. Sonographic appearance of revision carpal tunnel release and fat graft with absent transverse
Click to expand
A 74-year-old male with recurrent carpal tunnel syndrome who underwent revision surgery of the left wrist. Sonographic appearance of revision carpal tCredit: Shapiro SA et al. via J Clin Imaging Sci via Open-i (NIH) (Open Access (CC BY))
Median nerve images in carpal tunnel inlet (A and C) and carpal tunnel outlet (B and D).The arrow shows the transverse section of median nerve. (A) The normal median nerve at the carpal tunnel inlet m
Click to expand
Median nerve images in carpal tunnel inlet (A and C) and carpal tunnel outlet (B and D).The arrow shows the transverse section of median nerve. (A) ThCredit: Fu T et al. via PLoS ONE via Open-i (NIH) (Open Access (CC BY))

Critical Carpal Tunnel Exam Points

Thenar Atrophy = Urgent Surgery

APB wasting indicates SEVERE CTS with axonal damage. This is an urgent surgical indication. Do NOT delay with conservative measures. Counsel patient that motor recovery may be incomplete despite surgery. Sensory symptoms improve but thenar strength may not fully return.

Carpal Tunnel Boundaries

Floor = carpal bones (scaphoid, trapezium radially; pisiform, hamate ulnarly). Roof = transverse carpal ligament (flexor retinaculum). Contents = 10 structures: 4 FDS + 4 FDP + FPL + median nerve (most superficial and radial). Median nerve is at highest risk.

Palmar Cutaneous Branch Spared

Palmar sensation preserved in true CTS because the palmar cutaneous branch arises 5cm proximal to wrist crease and passes superficial to transverse carpal ligament. Use this to distinguish from C6 radiculopathy or more proximal median nerve lesions.

Electrodiagnostic Gold Standard

NCS confirms diagnosis and grades severity. Prolonged distal motor latency (greater than 4.5ms) and sensory latency (greater than 3.5ms). EMG shows denervation in thenar muscles if severe. May be normal in early mild disease. Compare to contralateral and ulnar nerve.

Mnemonic

9 TENDONS + 1 NERVE = 10Carpal Tunnel Contents

4
Four FDS tendons
Flexor digitorum superficialis (index, middle, ring, small)
4
Four FDP tendons
Flexor digitorum profundus (index, middle, ring, small)
1
One FPL tendon
Flexor pollicis longus (thumb flexor)
1
One median nerve
Most superficial and radial structure at risk

Memory Hook:9 tendons + 1 nerve = 10 structures. Median nerve is number 10 and most superficial!

Mnemonic

LOAFMedian Nerve Motor Supply (LOAF)

L
Lumbricals 1-2
First and second lumbricals (radial two)
O
Opponens pollicis
Opposition of thumb
A
Abductor pollicis brevis
KEY MUSCLE - test for motor function
F
Flexor pollicis brevis
Superficial head only (deep head = ulnar)

Memory Hook:LOAF muscles = what you can't do when median nerve fails - can't hold a loaf of bread!

Mnemonic

MEDIAN TRAPCTS Risk Factors

M
Masses
Ganglion, lipoma, anomalous muscles
E
Edema
Pregnancy, CHF, renal failure
D
Diabetes mellitus
Most common systemic association (10% prevalence)
I
Idiopathic
Most common overall (greater than 50%)
A
Arthritis
Rheumatoid (synovitis), osteoarthritis
N
Neuropathy
Hypothyroid, amyloid, acromegaly

Memory Hook:Median nerves get caught in a MEDIAN TRAP!

Mnemonic

PDTProvocative Tests - PDT

P
Phalen's test
Wrist flexion 60 seconds (68% sens, 73% spec)
D
Durkan's test
Direct compression 30 seconds (87% sens, 90% spec)
T
Tinel's sign
Tap over carpal tunnel (50% sens, 77% spec)

Memory Hook:PDT = Phalen's, Durkan's, Tinel's - test them all but Durkan's is best!

Overview and Epidemiology

Carpal tunnel syndrome (CTS) is the most common peripheral nerve compression neuropathy, resulting from compression of the median nerve beneath the transverse carpal ligament at the wrist. The condition affects 3-6% of the general population and accounts for approximately 90% of all entrapment neuropathies.

Epidemiology

Demographics:

  • Female predominance: 3:1 ratio (hormonal factors, smaller carpal tunnel)
  • Peak incidence: 40-60 years of age
  • Bilateral involvement: 50-60% of cases
  • Dominant hand: Typically more symptomatic
  • Occupational: Repetitive wrist flexion, vibration exposure

Risk Factors:

  • Idiopathic: Greater than 50% of cases (no identifiable cause)
  • Diabetes mellitus: 10% prevalence in diabetics vs 3% general population
  • Pregnancy: 2-7% incidence, usually resolves post-partum
  • Hypothyroidism: Myxedema deposition in tunnel
  • Rheumatoid arthritis: Synovial proliferation
  • Obesity: BMI greater than 30 increases risk 2-fold
  • Previous wrist fracture: Distal radius fractures (especially malunion)

Why CTS Matters for Exams

CTS is the most frequently tested nerve compression in orthopaedic exams. You must know: (1) the 10 structures in the tunnel, (2) why palmar sensation is spared, (3) provocative test sensitivity/specificity, (4) NCS criteria, (5) surgical anatomy including recurrent motor branch variations.

Anatomical illustration of median and ulnar nerves in the palm
Click to expand
Palmar hand anatomy showing median and ulnar nerve distribution: 1-ulnar nerve, 2-transverse carpal ligament (flexor retinaculum), 3-deep palmar branch, 4-anastomosis between median and ulnar nerves (Martin-Gruber), 5-thenar muscles, 6-hypothenar muscles. The median nerve passes deep to the transverse carpal ligament where compression occurs.Credit: Bordoni B et al. - J Pain Res (CC BY 4.0)

Anatomy

Median nerve anatomical variations and course through carpal tunnel
Click to expand
Median nerve anatomy and variations: (A) Anatomical illustration showing nerve course through wrist and hand, (B-H) Thenar motor branch (TMB) variation patterns - extraligamentous (50%, safest), subligamentous (30%), and transligamentous (20%, at risk during CTR), with corresponding cadaveric dissection photographs (C,E,G,I). Understanding these variations is critical for safe surgical release.Credit: Henry BM et al. - PLoS ONE (CC BY 4.0)

Carpal Tunnel Anatomy

The carpal tunnel is a fibro-osseous canal at the wrist formed by the concave arch of the carpal bones (floor) and the transverse carpal ligament (roof).

Boundaries:

  • Floor: Carpal bones arranged in two rows
    • Proximal row: Scaphoid (radial), lunate, triquetrum, pisiform (ulnar)
    • Distal row: Trapezium (radial), trapezoid, capitate, hamate (ulnar)
  • Roof: Transverse carpal ligament (flexor retinaculum)
    • Attachments: Scaphoid tubercle and trapezium (radial) to pisiform and hook of hamate (ulnar)
    • Length: Approximately 2.5-3cm
    • Thickness: 2-3mm (thickens with age and loading)

Contents (10 structures):

  1. Median nerve - most superficial and radial 2-5. Four FDS tendons - superficial layer 6-9. Four FDP tendons - deep to FDS
  2. FPL tendon - radial to FDP tendons

Median Nerve Position

The median nerve lies most superficial in the tunnel, directly beneath the transverse carpal ligament. This makes it vulnerable to compression from any increase in tunnel pressure or decrease in tunnel volume. The nerve is also the most radial structure, lying between FPL (radial) and FDS to index finger.

Median Nerve Anatomy

Course:

  • Enters forearm between two heads of pronator teres
  • Lies deep to FDS in forearm
  • Gives off anterior interosseous nerve (pure motor) in proximal forearm
  • Gives off palmar cutaneous branch 5-6cm proximal to wrist crease
  • Enters carpal tunnel deep to transverse carpal ligament
  • Exits tunnel and gives off recurrent motor branch to thenar muscles
  • Divides into digital branches for sensation

Palmar Cutaneous Branch:

  • Arises 5cm proximal to wrist crease
  • Passes superficial to transverse carpal ligament
  • Supplies sensation to thenar and central palm
  • Spared in true CTS - key diagnostic feature

Recurrent Motor Branch (Thenar Branch):

  • Anatomical variations (important for surgery):
    • Extraligamentous (50%): Exits distal to ligament (safest)
    • Subligamentous (30%): Travels under ligament then exits
    • Transligamentous (20%): Pierces through ligament (at risk during release)
  • Supplies thenar muscles (LOAF): Lumbricals 1-2, Opponens pollicis, Abductor pollicis brevis, Flexor pollicis brevis (superficial head)

Pathophysiology

Pressure-Ischemia Cascade

Pressure-Ischemia Sequence:

  1. Increased Intracarpal Pressure

    • Normal pressure: 2-10 mmHg
    • CTS pressure: 30-110 mmHg (threshold for symptoms = 30 mmHg)
    • Wrist flexion/extension increases pressure further
  2. Venous Congestion

    • Increased pressure → venous obstruction
    • Edema within epineurium
    • Further increases pressure (vicious cycle)
  3. Ischemia and Demyelination

    • Chronic ischemia → focal demyelination
    • Reversible at this stage with decompression
    • Manifests as sensory symptoms and prolonged latencies on NCS
  4. Axonal Damage

    • Severe chronic compression → axonal loss
    • Irreversible - leads to thenar atrophy
    • Wallerian degeneration occurs
    • Recovery limited even after decompression

Why Night Symptoms?

Nocturnal symptoms occur because: (1) During sleep, wrists naturally fall into flexion which increases tunnel pressure, (2) Dependent position of hands causes venous congestion, (3) Recumbent position redistributes fluid increasing edema. This is why night splinting in neutral position is effective.

Classification Systems

Clinical Severity Classification

GradeSymptomsExaminationManagement
MildIntermittent paresthesia, nocturnal symptomsNormal sensation, normal motor, positive provocative testsSplinting 6-8 weeks, activity modification
ModeratePersistent paresthesia, occasional weaknessSensory deficit in median distribution, positive Phalen's/Durkan'sInjection trial OR proceed to surgery
SevereConstant numbness, weakness, thenar wastingThenar atrophy, APB weakness, impaired 2PDUrgent carpal tunnel release

Clinical severity guides urgency of treatment. Mild cases warrant conservative trial. Severe cases require urgent surgery.

Nerve Conduction Study Classification

Severity Based on NCS Findings:

GradeSensory LatencyMotor LatencyEMG FindingsPrognosis
NormalLess than 3.5msLess than 4.5msNormalExcellent
MildGreater than 3.5msNormalNormalExcellent
ModerateProlonged or absentGreater than 4.5msNormalGood
SevereAbsentGreater than 6.5msFibrillationsGuarded
Very SevereAbsentAbsent or very prolongedChronic denervationPoor motor recovery

Key NCS Parameters:

  • Distal motor latency: Wrist to APB, normal less than 4.5ms
  • Sensory latency: Wrist to index/middle finger, normal less than 3.5ms
  • Sensory amplitude: Decreased in severe cases
  • Motor amplitude: Decreased indicates axonal loss
  • Compare to ulnar nerve: Internal control

EMG shows fibrillation potentials and positive sharp waves in APB if severe. Chronic changes include reduced recruitment and large motor unit potentials.

Palumbo Clinical Staging System

StageDescriptionExamination Findings
Stage 1Intermittent numbness/tinglingNormal exam, positive provocative tests
Stage 2Persistent symptoms, night wakingSensory deficit in median territory
Stage 3Motor weakness developingWeak APB, sensory loss
Stage 4Thenar atrophyVisible APB wasting, fixed sensory loss
Stage 5Complete palsyProfound weakness, absent sensation

Palumbo staging is useful for clinical grading and counseling about prognosis. Stages 1-2 have excellent outcomes. Stages 4-5 may have incomplete recovery.

Clinical Assessment

History

Classic Presentation:

  • Nocturnal paresthesia: Waking at night with numbness (75% of patients)
  • Flick sign: Shaking or flicking hand to relieve symptoms (pathognomonic)
  • Distribution: Thumb, index, middle, and radial half of ring finger
  • Palmar sensation preserved: Key distinguishing feature
  • Progression: Sensory → motor (weakness, clumsiness, dropping objects)

Aggravating Factors:

  • Sustained wrist flexion (driving, reading, phone use)
  • Repetitive gripping or pinching
  • Vibration exposure
  • Cold weather

Associated Features:

  • Pain radiating to forearm or shoulder (25%)
  • Difficulty with fine motor tasks (buttoning, writing)
  • Weakness of pinch grip

Flick Sign

The flick sign (patient shakes or flicks hand to relieve symptoms) has 93% sensitivity and 96% specificity for CTS. Ask: "What do you do when symptoms wake you at night?" If they demonstrate shaking/flicking, this is virtually diagnostic.

Examination

Inspection:

  • Thenar muscle bulk: Compare both hands with palms up
  • APB wasting: Depression at thenar eminence
  • Skin changes: Trophic changes in severe cases

Sensory Testing:

  • Light touch: Median nerve distribution (radial 3.5 digits palmar)
  • Two-point discrimination: Greater than 6mm abnormal (normal 2-5mm)
  • Semmes-Weinstein monofilaments: Objective sensory testing
  • Compare to ulnar territory: Little finger as control

Motor Testing:

  • Abductor pollicis brevis: KEY MUSCLE
    • Patient places hand palm-up on table
    • Ask to point thumb to ceiling against resistance
    • Palpate APB during contraction
    • Grade strength (0-5 scale)
  • Opponens pollicis: Touch thumb tip to little finger tip
  • Pinch strength: May be weak in advanced disease

Provocative Tests:

TestTechniquePositive FindingSensitivitySpecificity
Phalen'sMaximum wrist flexion 60 secondsParesthesia in median distribution68%73%
Reverse Phalen'sMaximum wrist extension 60 secondsParesthesia in median distribution48%76%
Tinel'sTap over carpal tunnel at wrist creaseElectric sensation in median distribution50%77%
Durkan'sDirect compression over tunnel 30 secondsParesthesia in median distribution87%90%
Tourniquet testBP cuff inflated above systolic for 60sReproduction of symptoms70%80%

Differential Diagnosis:

  • C6/C7 radiculopathy: Neck pain, reflex changes, palmar sensation affected
  • Pronator syndrome: Pain in proximal forearm, no nocturnal symptoms
  • Thoracic outlet syndrome: Provoked by arm elevation, ulnar distribution
  • Peripheral neuropathy: Symmetrical, stocking-glove, systemic disease
  • De Quervain's tenosynovitis: Radial wrist pain, Finkelstein's positive

Red Flags Requiring Further Investigation

  • Bilateral severe symptoms with rapid onset → consider cervical myelopathy
  • Numbness in palmar region → not true CTS, consider proximal lesion
  • Weakness without sensory symptoms → consider motor neuron disease or C8 radiculopathy
  • Atypical distribution → consider alternative diagnosis

Investigations

Nerve Conduction Studies (NCS)

Gold standard for diagnosis confirmation and severity grading.

Indications for NCS:

  • Atypical presentation
  • Bilateral severe symptoms
  • Confirm diagnosis before surgery
  • Medico-legal cases
  • Young patients (under 40)
  • Assess severity and prognosis

Technique:

  • Sensory NCS: Orthodromic (digit to wrist) or antidromic (wrist to digit)
    • Stimulate at wrist, record from index or middle finger
    • Measure distal sensory latency and amplitude
    • Normal latency less than 3.5ms
  • Motor NCS: Stimulate median nerve at wrist, record from APB
    • Measure distal motor latency
    • Normal latency less than 4.5ms
    • Compare to ulnar nerve (ADM)

Diagnostic Criteria:

  • Prolonged median sensory latency greater than 3.5ms
  • Prolonged median motor latency greater than 4.5ms
  • Median-ulnar sensory latency difference greater than 0.5ms
  • Median-ulnar motor latency difference greater than 1.0ms

Ultrasound

Increasing use as diagnostic tool:

  • Cross-sectional area (CSA): Greater than 10-12mm² at tunnel inlet
  • Flattening ratio: Anterior-posterior to medial-lateral diameter
  • Bowing of retinaculum: Displacement greater than 2mm
  • Dynamic assessment: Nerve movement with finger flexion
  • Identify masses: Ganglion, persistent median artery
Ultrasound of carpal canal showing median nerve and tendons
Click to expand
Transverse ultrasound of carpal canal at proximal (P) and distal (D) levels demonstrating key structures: SDFT (superficial digital flexor tendons), DDFT (deep digital flexor tendons), MN (median nerve), MA (median artery). The median nerve cross-sectional area greater than 10-12mm² suggests carpal tunnel syndrome.Credit: Turan E et al. - J. Vet. Sci. (CC BY 4.0)

Advantages:

  • Non-invasive, no electrical stimulation
  • Real-time visualization
  • Identifies structural causes
  • Can guide injection

Limitations:

  • Operator-dependent
  • Does not assess function
  • Cannot quantify severity like NCS

MRI

Not routine, reserved for:

  • Suspected mass lesion
  • Atypical presentation
  • Failed surgery
  • Research purposes
Axial MRI of carpal tunnel showing median nerve hyperintensity
Click to expand
Axial T2-weighted MRI of carpal tunnel demonstrating hyperintensity of the median nerve (white arrow) indicating nerve edema and inflammation - a finding in carpal tunnel syndrome. Asterisks mark the thenar and hypothenar muscle compartments. MRI is reserved for atypical presentations, suspected mass lesions, or failed surgery cases.Credit: Kasundra GM et al. - J Neurosci Rural Pract (CC BY 4.0)

Findings:

  • T2 hyperintensity of nerve
  • Nerve enlargement
  • Muscle edema (if acute denervation)
  • Thenar atrophy (chronic)

Laboratory Studies

Screen for associated conditions:

  • TSH (hypothyroidism)
  • HbA1c (diabetes)
  • Rheumatoid factor/anti-CCP (rheumatoid arthritis)
  • Serum protein electrophoresis (amyloid if suspected)

Management Algorithm

📊 Management Algorithm
carpal tunnel management algorithm
Click to expand
Management algorithm for carpal tunnelCredit: OrthoVellum

Treatment Pathway

First LineConservative Management

Mild to moderate CTS without thenar atrophy:

  • Night splinting in neutral wrist position for 6-8 weeks
  • Activity modification (avoid sustained flexion)
  • NSAIDs for symptom control (limited evidence)
  • Consider corticosteroid injection if splinting fails

Success rate: 30-50% with splinting, 60-80% short-term with injection

Second LineCorticosteroid Injection

If splinting fails or moderate symptoms:

  • Single injection 10-40mg methylprednisolone into tunnel
  • Ulnar to palmaris longus, proximal to wrist crease
  • Avoid intraneural injection (test with small volume first)
  • Relief within days, lasts weeks to months
  • Can repeat once, maximum 2-3 injections total

Success rate: 70-80% short-term relief, 20-30% long-term

DefinitiveSurgical Release

Indications: Severe symptoms, thenar atrophy, failed conservative treatment

  • Open or endoscopic carpal tunnel release
  • Day surgery under local or regional anesthesia
  • Divide transverse carpal ligament completely
  • Return to light activities 1-2 weeks, full activities 4-6 weeks

Success rate: 85-95% excellent outcomes

Night Splinting

Technique:

  • Wrist in neutral (0-5 degrees extension) NOT flexion or hyperextension
  • Worn during sleep for minimum 6-8 weeks
  • Full-time splinting not superior to night-only
  • More effective in mild disease, pregnancy, recent onset
  • Success rate 30-50% at 6 months

Activity Modification

Recommendations:

  • Avoid sustained wrist flexion (computer use, driving)
  • Take frequent breaks from repetitive tasks
  • Ergonomic adjustments (keyboard height, mouse position)
  • Modify sports grip (cycling, tennis)

Conservative management with splinting and activity modification is appropriate first-line treatment for mild to moderate CTS without thenar atrophy.

Corticosteroid Injection

Technique:

  • Position: Wrist slightly extended
  • Site: 1cm proximal to distal wrist crease, ulnar to palmaris longus
  • Angle: 45 degrees distally
  • Depth: Just past retinaculum (loss of resistance)
  • Test: Inject 0.5ml saline first - should feel no resistance
  • Medication: 1ml (10-40mg) methylprednisolone + 1ml local anesthetic
  • Post-injection: Splint for 2 weeks

Outcomes:

  • 70-80% short-term relief
  • 20-30% long-term benefit
  • Maximum 2-3 injections total

Injection provides diagnostic value and temporary relief. Most patients with moderate-severe disease will eventually require surgery.

Other Conservative Options

Limited Evidence:

  • Oral corticosteroids (short course only)
  • Vitamin B6 (no proven benefit in trials)
  • NSAIDs (symptom control only, no disease modification)
  • Diuretics (no evidence of efficacy)
  • Therapeutic ultrasound (inconsistent evidence)
  • Yoga/stretching (some evidence for symptom relief)

Most non-surgical interventions beyond splinting and injection have limited evidence supporting their use.

Surgical Technique

Open Carpal Tunnel Release

Indications:

  • Failed conservative treatment (6+ months)
  • Moderate to severe NCS changes
  • Thenar muscle atrophy or weakness
  • Persistent disabling symptoms
  • Patient preference for definitive treatment
  • Acute carpal tunnel (trauma, hemorrhage)

Setup:

  • Supine position, arm on hand table
  • Upper arm tourniquet (250 mmHg)
  • Prep and drape hand and forearm
  • Local anesthetic (1% lidocaine with epinephrine) OR regional block
  • Mark incision with wrist flexed then extended to avoid transverse crease

Incision:

  • Longitudinal incision in line with radial border of ring finger
  • From distal wrist crease to mid-palm
  • Length 3-4cm (extended release) or 2-3cm (mini-open)
  • Stay ulnar to thenar crease
  • Avoid crossing wrist crease transversely (hypertrophic scar)

Step-by-Step Technique:

  1. Skin and Subcutaneous Dissection

    • Incise skin with knife
    • Identify and protect palmar cutaneous branch (travels superficially)
    • Divide palmar fascia in line with incision
    • Identify transverse carpal ligament (white, fibrous band)
  2. Identify Landmarks

    • Palmaris longus: Surface landmark (ulnar to this)
    • Flexor carpi radialis: Radial boundary (avoid)
    • Ulnar neurovascular bundle: Ulnar boundary (stay radial to this)
  3. Divide Transverse Carpal Ligament

    • Insert mosquito forceps UNDER ligament to protect nerve
    • Elevate ligament away from nerve
    • Divide ligament with knife or scissors under direct vision
    • Release distally to superficial palmar arch (feel "give")
    • Release proximally into antebrachial fascia (2cm proximal to crease)
    • Ensure COMPLETE division (run probe underneath)
  4. Inspect Tunnel Contents

    • Visualize median nerve (should be flattened, may be hourglass)
    • Check for anatomical variations: Bifid nerve, persistent median artery
    • Look for masses: Ganglion, lipoma
    • Assess synovium: Proliferative synovitis may need debulking
    • DO NOT perform internal neurolysis (increases scar, worse outcomes)
  5. Hemostasis and Closure

    • Release tourniquet
    • Achieve meticulous hemostasis (prevents hematoma)
    • DO NOT repair transverse carpal ligament (would recreate compression)
    • Close skin only with interrupted 4-0 nylon sutures
    • Apply bulky dressing in functional position
    • Allow immediate finger ROM

Technical Pearls:

  • Divide ligament completely (incomplete release = most common cause of failure)
  • Extend release into forearm fascia proximally
  • Extend release to superficial arch distally
  • Protect recurrent motor branch (exits ulnar side of nerve distally)
  • If thenar muscles not visible, assume extraligamentous recurrent branch

Structures at Risk:

  • Palmar cutaneous branch: Superficial, easily injured with skin incision
  • Recurrent motor branch: Variable course (transligamentous in 20%)
  • Superficial palmar arch: Distal limit of release
  • Ulnar nerve and artery: Ulnar boundary of incision

Meticulous attention to anatomical landmarks and direct visualization of the transverse carpal ligament ensures safe and complete release with excellent long-term outcomes.

Endoscopic Carpal Tunnel Release

Advantages over Open:

  • Smaller incision (1-2cm)
  • Less pillar pain
  • Faster recovery (grip strength at 2 weeks vs 6 weeks)
  • Earlier return to work (2 weeks vs 4 weeks)
  • Less scar tenderness

Disadvantages:

  • Learning curve (30-50 cases)
  • Slightly higher nerve injury risk (especially during learning)
  • Cannot address masses or synovitis
  • Cannot inspect nerve
  • Requires specialized equipment
  • Contraindicated in certain scenarios

Contraindications:

  • Suspected mass lesion
  • Previous carpal tunnel surgery
  • Severe wrist arthritis with osteophytes
  • Anomalous anatomy (bifid median nerve)
  • Surgeon inexperience

Techniques:

Single Portal (Agee System):

  • 1.5cm transverse incision at distal wrist crease
  • Insert cannula with blade through tunnel
  • Visualize ligament and divide under direct vision
  • Exit point in mid-palm

Two Portal (Chow Technique):

  • Proximal portal at distal wrist crease
  • Distal portal in mid-palm
  • Pass cannula through both portals
  • Visualize and divide ligament from underneath

Outcomes:

  • Similar long-term results to open (90-95% success)
  • Faster initial recovery
  • Meta-analyses show no difference at 6-12 months
  • Choose based on surgeon experience

The decision between open and endoscopic techniques should be based on surgeon training and experience, patient anatomy, and clinical circumstances rather than perceived differences in long-term outcomes.

Revision Carpal Tunnel Release

Indications:

  • Incomplete initial release (most common)
  • Recurrent compression (scar tissue)
  • Persistent symptoms despite adequate release
  • Iatrogenic nerve injury

Workup Before Revision:

  • Repeat NCS (compare to pre-operative)
  • Ultrasound or MRI (assess for scar, masses)
  • Rule out alternative diagnosis (cervical radiculopathy)
  • Review operative note from initial surgery
  • Consider wrong diagnosis initially

Technique:

  • Extended open approach (wider exposure)
  • Careful dissection through scar
  • Identify median nerve proximally in forearm (safe zone)
  • Neurolysis if encased in scar
  • Extended release proximally and distally
  • Consider hypothenar fat flap coverage of nerve
  • Consider vein wrapping to prevent recurrent adhesions

Outcomes:

  • Less predictable than primary release (70-80% improvement)
  • Counsel about incomplete relief
  • Higher complication rate

Patient expectations must be managed appropriately as revision surgery carries higher risks and lower success rates than primary release. Thorough pre-operative workup is essential to confirm the indication.

Complications

Clinical photographs showing ulnar nerve palsy complication after carpal tunnel release
Click to expand
Iatrogenic ulnar nerve injury following carpal tunnel release (rare but serious complication): (A) Palmar view showing thenar wasting and healed surgical scar, (B) Lateral view demonstrating clawing of the ring and little fingers with positive Wartenberg's sign - ulnar nerve territory deficits. This case required secondary ulnar nerve repair. Careful surgical technique minimizes nerve injury risk.Credit: Yoong P et al. - Indian J Plast Surg (CC BY 4.0)

Complications of Carpal Tunnel Release

ComplicationIncidencePresentationManagement
Pillar pain10-20%Pain at thenar/hypothenar eminence for 3-6 monthsReassurance, hand therapy, resolves spontaneously
Incomplete release2-5%Persistent symptoms unchanged from pre-opRepeat NCS, revision surgery if confirmed
Scar tenderness5-10%Tender incision scar for monthsDesensitization, silicone gel, massage
Median nerve injury0.1-0.5%Immediate post-op numbness or weaknessUrgent exploration if transection suspected
Recurrent motor branch injury0.3-1%Thenar weakness post-operativelyExploration and repair if identified early
Vascular injury (arch)Under 1%Hematoma, brisk bleedingImmediate control, vascular repair
CRPS1-5%Severe pain, stiffness, autonomic changesMultidisciplinary pain management, PT/OT
InfectionUnder 1%Wound erythema, drainage, feverAntibiotics, wound care, possible I&D
Bowstringing of tendonsRareWeakness of grip, visible tendon prominenceRare, usually asymptomatic

Pillar Pain

Most common complication (10-20% of patients):

  • Mechanism: Separation of thenar and hypothenar origins from transverse ligament
  • Presentation: Aching pain at bases of thumb and hypothenar eminences
  • Worse with grip and pinch
  • Typically resolves by 3 months, some up to 6-12 months
  • Management: Reassurance, grip strengthening, thenar massage
  • Prevention: Partial ligament release NOT recommended (risk incomplete decompression)

Incomplete Release

Second most common cause of persistent symptoms:

  • Failure to divide ligament completely distally or proximally
  • Inadequate proximal release of antebrachial fascia
  • Failure to identify anomalous anatomy
  • Diagnosis: Repeat NCS, ultrasound showing residual compression
  • Management: Revision open CTR with extended release

Nerve Injuries

Median nerve laceration:

  • Rare (0.1-0.3%) but devastating
  • Present immediately post-op with dense numbness and weakness
  • Management: Urgent exploration and primary repair
  • May need nerve graft if gap

Recurrent motor branch injury:

  • More common (0.3-1%), especially with transligamentous variant
  • Present with thenar weakness
  • Management: If identified within 72 hours, explore and repair
  • Late recognition: conservative management, tendon transfers if needed

Complex Regional Pain Syndrome (CRPS)

Severe complication (1-5%):

  • Disproportionate pain, stiffness, swelling
  • Autonomic changes (temperature, color, sweating)
  • Early recognition critical
  • Management: Multidisciplinary (pain specialist, PT/OT, psychology)
  • Gabapentin, vitamin C prophylaxis (some evidence)
  • Sympathetic blocks if severe

Postoperative Care and Recovery

Postoperative Protocol

Day 0-7Immediate Post-Op

Protection phase:

  • Bulky dressing with wrist in neutral
  • Elevate hand above heart (prevent edema)
  • Immediate finger ROM - flex and extend fingers hourly
  • Keep dressing dry
  • Ice for pain control
  • Oral analgesia (paracetamol, NSAIDs)
Week 1-2Early Mobilization

Wound check and suture removal:

  • Remove dressing at 1 week
  • Remove sutures at 10-14 days
  • Begin scar massage with moisturizer
  • Light activities of daily living permitted
  • Avoid heavy lifting (greater than 2kg)
  • Grip strengthening exercises - squeeze soft ball
Week 2-6Progressive Loading

Return to function:

  • Progressive grip strengthening
  • Desensitization if scar tender
  • Full finger ROM expected
  • Return to desk work 1-2 weeks
  • Return to manual labor 4-6 weeks (open) or 2-4 weeks (endoscopic)
  • Driving when can control vehicle safely (typically 1-2 weeks)
Month 3+Final Recovery

Expected outcomes:

  • Sensory recovery: Complete by 3-6 months
  • Motor recovery: Depends on pre-op severity, may take 6-12 months
  • Grip strength: Returns to baseline by 3-6 months
  • Pillar pain: Should resolve by 3-6 months
  • Scar maturation: 6-12 months

Hand Therapy

Indications:

  • Severe pre-operative stiffness
  • Pillar pain persisting beyond 6 weeks
  • CRPS symptoms
  • Slow recovery of function
  • Grip weakness
  • Scar sensitivity

Therapy Components:

  • Edema control (elevation, retrograde massage)
  • Scar desensitization and massage
  • Grip strengthening (progressive resistance)
  • Pinch strengthening
  • Tendon gliding exercises
  • Return to work conditioning

Expected Recovery Timeline

ParameterTimelineNotes
Pain reliefImmediate to weeksNocturnal symptoms resolve immediately
Sensory recoveryWeeks to monthsDepends on severity, mild = weeks
Motor recoveryMonthsIncomplete if severe atrophy
Grip strength3-6 monthsOpen slower than endoscopic initially
Return to desk work1-2 weeksVariable by patient
Return to manual work4-6 weeks open, 2-4 weeks endoDepends on demands
Final outcome3-6 months85-95% satisfied

Outcomes and Prognosis

Success Rates

Overall surgical outcomes:

  • Excellent/Good: 85-95% patient satisfaction
  • Symptom relief: 90-95% for nocturnal paresthesia
  • Sensory recovery: 80-90% complete if mild-moderate pre-op
  • Motor recovery: Variable - depends on severity and duration

Prognostic Factors:

FactorFavorable PrognosisPoor Prognosis
Symptom durationLess than 1 yearGreater than 2 years
SeverityMild to moderate (no atrophy)Severe with thenar wasting
AgeUnder 50 yearsOver 65 years
NCS findingsSensory changes onlyAbsent responses, denervation
DiabetesNo diabetesDiabetes present
ObesityNormal BMIBMI greater than 35
Worker's compensationNo WC claimActive WC claim
Bilateral symptomsUnilateralBilateral severe

Functional Outcomes

Boston Carpal Tunnel Questionnaire (BCTQ):

  • Most widely used validated outcome measure
  • Symptom Severity Scale (11 questions)
  • Functional Status Scale (8 questions)
  • Improvement of 1.0+ points clinically significant

Mean Improvement Post-CTR:

  • Symptom score improves from 3.2 to 1.5 (out of 5)
  • Functional score improves from 2.8 to 1.4
  • Maximal improvement at 3-6 months

Patient Satisfaction:

  • 85-90% would have surgery again
  • 10-15% disappointed (persistent symptoms or complications)
  • Higher satisfaction with appropriate patient selection

Recurrence

True recurrence (scar tissue causing recompression):

  • Incidence: 5-10% over 10 years
  • Risk factors: Diabetes, rheumatoid arthritis, dialysis
  • Presentation: Gradual return of symptoms after initial relief
  • Diagnosis: Repeat NCS, ultrasound showing recurrent compression
  • Management: Revision CTR with neurolysis ± coverage (fat flap, vein wrap)

Persistent symptoms (inadequate release):

  • More common than true recurrence
  • Never had symptom-free interval post-op
  • Due to incomplete ligament division
  • Management: Revision CTR if confirmed on imaging

Evidence Base

Level I
📚 Gerritsen et al (JAMA 2002)
Key Findings:
  • Surgery vs splinting for CTS (176 patients)
  • Surgery superior at 3 months (92% success vs 72%)
  • Surgery superior at 18 months (90% vs 60%)
  • 70% of splint group eventually required surgery
Clinical Implication: Surgery is more effective than splinting for established moderate CTS. Conservative treatment is reasonable for mild cases but many progress to requiring surgery.
Source: Randomized Controlled Trial

Level I
📚 Scholten et al (Cochrane 2007)
Key Findings:
  • 13 RCTs comparing open vs endoscopic CTR
  • Similar long-term outcomes (symptom relief, satisfaction)
  • Endoscopic: faster grip strength recovery (2 weeks vs 6-8 weeks)
  • Endoscopic: earlier return to work (18 vs 28 days)
  • Endoscopic: slightly higher transient nerve injury during learning curve
Clinical Implication: Both techniques are effective. Choose based on surgeon experience. Endoscopic offers faster initial recovery but similar long-term outcomes.
Source: Systematic Review

Level I
📚 Marshall et al (Cochrane 2013)
Key Findings:
  • Local corticosteroid injection vs placebo (12 trials)
  • Significant short-term benefit at 1 month (improved symptoms)
  • Effect diminishes by 3 months
  • No long-term benefit over placebo at 6-12 months
  • 25% still improved at 1 year (suggests milder disease)
Clinical Implication: Injection provides temporary symptom relief. Useful for diagnostic confirmation and pregnancy-related CTS. Not durable treatment for most patients.
Source: Systematic Review

Level II
📚 Huisstede et al (Arch Phys Med Rehabil 2010)
Key Findings:
  • Night splinting in neutral position effective for mild-moderate CTS
  • Neutral position superior to flexion or extension
  • 6-8 weeks minimum trial recommended
  • More effective in recent onset (less than 1 year)
  • 30-50% success rate at avoiding surgery
Clinical Implication: Splinting is effective first-line treatment for mild-moderate CTS without thenar atrophy. Trial for 6-8 weeks before considering surgery.
Source: Systematic Review

Level III
📚 Bland (J Hand Surg Br 2007)
Key Findings:
  • Natural history of untreated CTS (354 hands)
  • 34% improved spontaneously over 10 months
  • 23% unchanged
  • 43% worsened
  • Only 8% developed thenar weakness (rare progression)
Clinical Implication: Not all CTS progresses. Conservative approach reasonable for mild intermittent symptoms. Progression to severe disease with atrophy is uncommon.
Source: Prospective Cohort

Level I
📚 Atroshi et al (JAMA 2009)
Key Findings:
  • Surgery vs placebo surgery for CTS (116 patients)
  • Surgery group: significant improvement in symptoms (97%)
  • Placebo group: some improvement (51%) - placebo effect
  • Difference maintained at 12 months
  • Confirms surgery is effective beyond placebo
Clinical Implication: Carpal tunnel release is effective beyond placebo effect. However, substantial placebo response emphasizes importance of accurate diagnosis.
Source: Randomized Controlled Trial

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

Scenario 1: Classic CTS Presentation

EXAMINER

"A 52-year-old woman presents with 8 months of waking at night with numbness in her right hand. She shakes her hand for relief. Her symptoms are worse after driving. Examination shows normal thenar bulk, positive Phalen's test. How would you manage this patient?"

EXCEPTIONAL ANSWER
This is a classic presentation of carpal tunnel syndrome with nocturnal paresthesia, the flick sign, and provocation with sustained wrist flexion. My initial assessment would confirm the median nerve distribution of symptoms - thumb, index, middle, and radial ring finger - and verify that palmar sensation is preserved which confirms the lesion is at the carpal tunnel level. On examination, I would specifically assess thenar muscle bulk comparing both hands, test abductor pollicis brevis strength, and perform all three provocative tests including Phalen's, Durkan's, and Tinel's. Given the normal thenar muscles, this indicates mild to moderate severity. My initial management would be conservative with night splinting in neutral wrist position for 6-8 weeks combined with activity modification. I would consider nerve conduction studies to confirm the diagnosis and quantify severity. If symptoms persist despite adequate conservative trial, I would recommend carpal tunnel release with expected 90-95% success rate. I would counsel about open versus endoscopic approaches, both having similar long-term outcomes.
KEY POINTS TO SCORE
Recognize classic presentation: nocturnal symptoms, flick sign
Confirm median nerve distribution, palmar sensation preserved
Normal thenar bulk = not severe = trial conservative first
NCS confirms diagnosis and severity
Surgery if conservative fails after 6-8 weeks
COMMON TRAPS
✗Proceeding directly to surgery without conservative trial
✗Not examining for thenar atrophy
✗Confusing with C6 radiculopathy (would affect palmar sensation)
✗Not testing APB specifically for motor function
LIKELY FOLLOW-UPS
"What are the exact contents of the carpal tunnel? (9 tendons + 1 nerve)"
"Why is palmar sensation preserved? (Palmar cutaneous branch proximal to tunnel)"
"How would you perform an open carpal tunnel release? (Detail surgical steps)"
VIVA SCENARIOChallenging

Scenario 2: Severe CTS with Thenar Wasting

EXAMINER

"A 65-year-old diabetic man presents with constant numbness and difficulty buttoning his shirt. On examination, there is obvious thenar muscle wasting and weakness of thumb abduction. What is your management?"

EXCEPTIONAL ANSWER
This is severe carpal tunnel syndrome as evidenced by thenar atrophy and functional motor deficit. The thenar wasting indicates advanced disease with axonal loss, and the diabetes is a negative prognostic factor. I would confirm the distribution of numbness is in median nerve territory and assess the severity of motor weakness, specifically testing abductor pollicis brevis strength. I would obtain urgent nerve conduction studies which I expect to show absent or severely prolonged responses with denervation on EMG. Given the severity indicated by visible thenar atrophy, I would recommend urgent carpal tunnel release rather than a trial of conservative measures, as further delay would risk permanent motor deficit. I would use an open approach for direct visualization of the nerve and complete ligament release. However, I must counsel the patient that motor recovery may be incomplete given the established atrophy - while sensory symptoms typically improve dramatically after surgery, thenar strength may not return to normal. The diabetes also increases his risk of slower recovery and potential complications. Post-operatively, he would benefit from hand therapy for strengthening.
KEY POINTS TO SCORE
Thenar atrophy = severe CTS = urgent surgery indicated
Do NOT delay with conservative measures when atrophy present
Diabetes is negative prognostic factor
Counsel about incomplete motor recovery
Sensory symptoms improve but motor may not
COMMON TRAPS
✗Recommending splinting or injection when atrophy is present
✗Promising full recovery (motor recovery may be incomplete)
✗Not recognizing urgency of surgical decompression
✗Not counseling about realistic expectations
LIKELY FOLLOW-UPS
"What is the pathophysiology of thenar atrophy? (Axonal loss from chronic ischemia)"
"What muscles make up the thenar eminence? (LOAF - but only APB, OP, FPB superficial from median)"
"What are the variations of the recurrent motor branch? (Extra-, sub-, transligamentous)"
VIVA SCENARIOCritical

Scenario 3: Failed Carpal Tunnel Release

EXAMINER

"A 45-year-old woman returns 6 months after open carpal tunnel release with persistent symptoms identical to pre-operative. Her nerve conduction studies showed severe CTS pre-operatively. What is your approach?"

EXCEPTIONAL ANSWER
Persistent symptoms after carpal tunnel release requires systematic evaluation to determine the cause. The key first question is whether she ever had a symptom-free interval post-operatively. If symptoms persisted from day one, this suggests incomplete release. If she had initial relief followed by recurrence, this suggests true recurrence from scar tissue. I would take a detailed history about the nature and distribution of symptoms, examine the surgical scar for tenderness or neuromas, and specifically assess thenar muscle function and sensory distribution. The differential diagnosis includes: incomplete release of the transverse carpal ligament which is the most common cause, wrong initial diagnosis such as cervical radiculopathy or thoracic outlet syndrome, true recurrence from scar tissue, or iatrogenic nerve injury at the time of surgery. I would obtain repeat nerve conduction studies comparing to the pre-operative studies. I would also consider ultrasound or MRI to visualize the median nerve and assess for residual compression or scarring. If incomplete release is confirmed, I would offer revision open carpal tunnel release with extended proximal and distal division of any remaining ligament. I would counsel that revision surgery has less predictable outcomes than primary surgery, with approximately 70-80% improvement rate. If the diagnosis is uncertain or nerve appears damaged, referral to a peripheral nerve specialist may be warranted.
KEY POINTS TO SCORE
Distinguish persistent symptoms (incomplete) from recurrence (scar)
Incomplete release is most common cause of failure
Repeat NCS and compare to pre-operative studies
Consider wrong initial diagnosis (cervical, proximal median, thoracic outlet)
Revision surgery less predictable than primary (70-80% success)
COMMON TRAPS
✗Immediately offering repeat surgery without systematic workup
✗Not considering alternative diagnoses
✗Not obtaining imaging to assess for incomplete release vs scar
✗Promising excellent outcomes with revision (worse than primary)
LIKELY FOLLOW-UPS
"How would you perform revision carpal tunnel release? (Extended approach, proximal dissection)"
"What is pillar pain and how common is it? (10-20%, thenar/hypothenar pain, resolves 3-6 months)"
"What coverage options exist for revision? (Hypothenar fat flap, vein wrap)"

MCQ Practice Points

Carpal Tunnel Contents

Q: How many structures pass through the carpal tunnel?

A: 10 structures - Nine flexor tendons (4 FDS, 4 FDP, 1 FPL) plus the median nerve. The median nerve is the most superficial and radial structure. Note that the ulnar nerve and artery pass through Guyon's canal, NOT the carpal tunnel.

Palmar Cutaneous Branch

Q: Why is palmar sensation preserved in carpal tunnel syndrome?

A: The palmar cutaneous branch of the median nerve branches 5-6cm proximal to the wrist crease and passes superficial to the transverse carpal ligament. Therefore it is not compressed in the tunnel. This is a key feature that distinguishes CTS from more proximal median nerve lesions or C6 radiculopathy.

LOAF Muscles

Q: Which muscles are supplied by the recurrent motor branch of the median nerve?

A: LOAF - Lumbricals 1 and 2, Opponens pollicis, Abductor pollicis brevis, Flexor pollicis brevis (superficial head only). The deep head of FPB is supplied by the ulnar nerve. Adductor pollicis is also ulnar nerve.

Most Sensitive Test

Q: Which clinical test has the highest sensitivity for diagnosing CTS?

A: Durkan's compression test (87% sensitivity, 90% specificity) - direct compression over the carpal tunnel for 30 seconds. This is more sensitive than Phalen's test (68% sensitivity) or Tinel's sign (50% sensitivity). However, Phalen's is more commonly asked about in exams.

NCS Diagnostic Criteria

Q: What are the nerve conduction criteria for diagnosing CTS?

A: Prolonged distal motor latency greater than 4.5ms (wrist to APB) and/or prolonged sensory latency greater than 3.5ms (wrist to digit). May also see reduced amplitudes if severe. Always compare to ulnar nerve as internal control. Median-ulnar sensory latency difference greater than 0.5ms is significant.

Recurrent Motor Branch Variations

Q: What is the most common anatomical variant of the recurrent motor branch?

A: Extraligamentous (50%) - the motor branch exits the median nerve distal to the transverse carpal ligament. This is the safest variant during surgery. Subligamentous (30%) travels under the ligament before exiting. Transligamentous (20%) pierces through the ligament and is at risk during endoscopic release.

Most Common Post-Op Complication

Q: What is the most common complication after carpal tunnel release?

A: Pillar pain (10-20% incidence) - aching pain at the thenar and hypothenar eminences due to separation of muscle origins from the divided ligament. Typically resolves spontaneously by 3-6 months. Managed with reassurance and hand therapy.

Pregnancy-Related CTS

Q: How should you manage carpal tunnel syndrome in pregnancy?

A: Conservative management - night splinting in neutral position is first-line. Symptoms usually resolve post-partum (2-4 weeks after delivery). Corticosteroid injection is safe if splinting fails. Avoid surgery during pregnancy unless severe progressive motor loss. Most cases resolve without intervention.

Australian Context

Carpal tunnel syndrome is extremely common in Australian practice with prevalence similar to international data at 3-6% of the population. Higher rates are observed in certain occupational groups including meat processing and manufacturing workers.

Nerve conduction studies are widely available across Australia, with most performed by neurologists or clinical neurophysiologists. Ultrasound assessment is increasingly used by hand surgeons and musculoskeletal radiologists as an adjunct diagnostic tool.

Most carpal tunnel release procedures are performed as day surgery under local anesthetic or regional block. Both open and endoscopic techniques are commonly used by Australian hand surgeons. The Australian Hand Surgery Society provides practice recommendations, and RACS Guidelines outline informed consent requirements.

Workers compensation claims for CTS are common in manual workers and require careful documentation of occupational history. These cases may need workplace assessment and ergonomic modifications as part of the management plan.

Medico-Legal Considerations

Informed Consent Must Include:

  • Nature of condition and natural history
  • Conservative treatment options and success rates
  • Surgical risks including nerve injury (0.1-0.5%)
  • Incomplete relief especially if thenar atrophy present
  • Pillar pain (10-20%)
  • CRPS (rare but serious)
  • Recovery timeline and return to work expectations

Documentation Requirements:

  • Detailed clinical examination findings
  • Severity assessment (mild/moderate/severe)
  • Thenar muscle assessment and strength grading
  • Nerve conduction study results
  • Conservative treatment attempts and duration
  • Operative findings (especially if incomplete ligament, masses)

Common Litigation Issues:

  • Nerve injury (transection of median or recurrent motor branch)
  • Incomplete release with persistent symptoms
  • CRPS development
  • Delayed diagnosis leading to irreversible thenar atrophy

Australian Evidence

Limited Australian-specific research but local practice aligns with international evidence. AOANJRR does not track CTR (not arthroplasty). Most evidence comes from international RCTs and systematic reviews.

CARPAL TUNNEL SYNDROME

High-Yield Exam Summary

Key Anatomy

  • •Tunnel contents: 9 tendons (4 FDS + 4 FDP + FPL) + median nerve = 10 total
  • •Floor = carpal bones; Roof = transverse carpal ligament (2.5-3cm long)
  • •Median nerve most superficial and radial (at risk)
  • •Palmar cutaneous branch: 5cm proximal, travels superficial (SPARED)
  • •Recurrent motor branch: Extraligamentous 50%, subligamentous 30%, transligamentous 20%
  • •LOAF muscles: Lumbricals 1-2, Opponens, APB, FPB superficial head

Clinical Diagnosis

  • •Classic triad: Nocturnal paresthesia + flick sign + median distribution
  • •Distribution: Thumb, index, middle, radial half ring (palmar ONLY)
  • •Thenar atrophy = SEVERE (APB wasting, urgent surgery needed)
  • •Provocative tests: Durkan's 87% sens (best), Phalen's 68% sens, Tinel's 50% sens
  • •Differential: C6 radiculopathy (palmar sensation affected), pronator syndrome, TOS

Investigations

  • •NCS gold standard: Motor latency greater than 4.5ms, sensory greater than 3.5ms
  • •EMG: Denervation in APB if severe (fibrillations, positive sharp waves)
  • •Ultrasound: Nerve CSA greater than 10mm² at inlet, can identify masses
  • •MRI not routine (only if mass or atypical)
  • •Screen: TSH (hypothyroid), HbA1c (diabetes), RF (RA)

Management Algorithm

  • •Mild-moderate WITHOUT atrophy: Splint neutral position 6-8 weeks first
  • •Injection: 70-80% short-term relief, 20-30% long-term, limit 2-3 max
  • •Severe OR thenar atrophy: Urgent CTR (do NOT delay)
  • •Surgery success: 85-95% excellent outcomes
  • •Open vs endoscopic: Similar long-term, endoscopic faster recovery

Surgical Technique (Open CTR)

  • •Incision: Longitudinal in line with ring finger, ulnar to thenar crease, 3-4cm
  • •Protect palmar cutaneous branch (superficial), recurrent motor branch (variable)
  • •Divide TCL completely: Distal to superficial arch, proximal into forearm 2cm
  • •Do NOT repair ligament (recreates compression)
  • •Do NOT perform neurolysis (increases scar, worse outcomes)

Complications

  • •Pillar pain: 10-20%, thenar/hypothenar ache, resolves 3-6 months
  • •Incomplete release: 2-5%, most common cause persistent symptoms
  • •Median nerve injury: 0.1-0.5%, urgent exploration if suspected
  • •Recurrent motor branch injury: 0.3-1%, thenar weakness
  • •CRPS: 1-5%, severe pain/stiffness, multidisciplinary management

Exam Favorites

  • •Why palmar sensation spared? Palmar cutaneous branch proximal to tunnel
  • •Most sensitive test? Durkan's compression (87% sens, 90% spec)
  • •Thenar atrophy management? Urgent surgery, counsel incomplete motor recovery
  • •Most common complication? Pillar pain 10-20%, resolves 3-6 months
  • •NCS criteria? Motor greater than 4.5ms, sensory greater than 3.5ms
  • •Pregnancy CTS? Splinting first-line, usually resolves post-partum
Quick Stats
Reading Time131 min
Related Topics

Animal Bites

Anterior Interosseous Nerve Anatomy

Blood Supply of the Forearm

Boutonniere Deformity